Catalyst Edge · Scanner · Tickers · APUS
CATALYST DOSSIER · UPDATED 2026-09-22

$APUS

Unclassified · convergence — · conviction —
Convergence Score
—
Conviction
—
Signals Firing
0
Track Record
2/2
Quick tools:🃏 Swipe deck🎯 Today verdict

Price & Live Quote

Loading live quote & chart…

Practice trade tools

Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.

Paper trade unavailable: missing risk-bounded frame

Reference only. Not financial advice. No brokerage order is placed.

Why $APUS?

APUS -6 WATCH biotech

Quantitative

  • Net Income (CY2026Q2): $-20.2M (-657.8% YoY)

Catalysts

  • Multi-spoke convergence: 6 convergent signals fired: auto_macro_credit_spreads, auto_macro_edgar_fts, auto_macro_eia_petroleum, auto_macro_inflation_expectations, auto_macro_move_index

Risks

  • Position-sizing discipline: Conviction WATCH (-6 score) — size accordingly; no specific catalyst-fade risk flagged

Bear case

  • Multiple compression: If breadth deteriorates, biotech-wide multiples re-rate lower regardless of pick-specific thesis

Sympathy basket (cerebro)

  • LXFR via materials r=+0.98 sympathetic (score 19)
  • ASPI via materials r=+0.98 sympathetic (score 16)
  • ACVA via industrials r=+0.88 sympathetic (score 24)
  • SFL via industrials r=+0.88 sympathetic (score 16)
  • CMRC via tech r=+0.80 sympathetic (score 23)
  • ORCL via tech r=+0.80 sympathetic (score 20)

Signals Firing

No active signals this cycle.
Each tag is a spoke that flagged this ticker today. Weights tuned weekly against published outcomes.

Pick Track Record

DateListNext-day max runNext-day closeHit +2%?
2026-08-24sec_top_gappers+12.6%+4.6%✓ hit
2026-08-24sec_top_moat_emerging+12.6%+4.6%✓ hit
Lifetime: 2/2 wins · hit-rate 100.0% on +2% intraday

Earnings Catalyst

No recent earnings event.

Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks and its losses — see the trust report and methodology. Not financial advice. Confirm independently before trading.